UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Journal for immunotherapy of cancer, 2019-02, Vol.7 (1), p.38-14, Article 38

2019

Volltextzugriff (PDF)

A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2410574

2024

Volltextzugriff (PDF)

Novel Multi-Antigen Orf-Virus-Derived Vaccine Elicits Protective Anti-SARS-CoV-2 Response in Monovalent and Bivalent Formats

Vaccines (Basel), 2024-05, Vol.12 (5), p.490

2024

Volltextzugriff (PDF)

Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL Methodology

CPT: pharmacometrics and systems pharmacology, 2018-04, Vol.7 (4), p.228-236

2018

Volltextzugriff (PDF)

Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway

Kidney international, 2001-07, Vol.60 (1), p.83-86

2001

Volltextzugriff (PDF)

Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor

The Journal of pharmacology and experimental therapeutics, 2002-03, Vol.300 (3), p.952-957

2002

Volltextzugriff (PDF)

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: Pharmacokinetic and pharmacodynamic considerations

Clinical pharmacokinetics, 2004, Vol.43 (14), p.963-981

2004

Volltextzugriff (PDF)

Anticoagulation With Argatroban for Elective Percutaneous Coronary Intervention: Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationship of Coagulation Parameters

Journal of clinical pharmacology, 2011-06, Vol.51 (6), p.805-818

2011

Volltextzugriff (PDF)

A novel μ-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants

Biomicrofluidics, 2013-09, Vol.7 (5), p.56502-56502

2013

Volltextzugriff (PDF)

408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A248-A248

2020

Volltextzugriff (PDF)

The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow

Platelets (Edinburgh), 2015-02, Vol.26 (1), p.59-66

2015

Volltextzugriff (PDF)

P3.02c-091 Final Phase Ib Results of RNActive® Cancer Vaccine BI 1361849 and Local Radiation as Maintenance Therapy for Stage IV NSCLC

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1333-S1334

2017

Volltextzugriff (PDF)

P3.02c-091 Final Phase Ib Results of RNActive® Cancer Vaccine BI 1361849 and Local Radiation as Maintenance Therapy for Stage IV NSCLC: Topic: IT Clinical

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1333-S1334

2017

Volltextzugriff (PDF)

Using ImageJ for the quantitative analysis of flow-based adhesion assays in real-time under physiologic flow conditions

Platelets (Edinburgh), 2010, Vol.21 (1), p.60-66

2010

Volltextzugriff (PDF)

Platelet–leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors

Journal of antimicrobial chemotherapy, 2008-11, Vol.62 (5), p.1118-1121

2008

Volltextzugriff (PDF)

Phenotypic differences of human neutrophils of carriers of the PSGL-1 A and B-allele in binding to immobilised P-selectin under flow conditions

Thrombosis research, 2011-02, Vol.127 (2), p.105-110

2011

Volltextzugriff (PDF)

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or anti-platelet therapy: pharmacokinetic and pharmacodynamic considerations

Clinical pharmacokinetics, 2004-12, Vol.43 (14), p.963

2004

Volltextzugriff (PDF)

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates

Thrombosis research, 2003, Vol.111 (4-5), p.251-257

2003

Volltextzugriff (PDF)

A novel ?-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants

Biomicrofluidics, 2013-01, Vol.7 (5)

2013

Volltextzugriff (PDF)

Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators

Thrombosis research, 2004, Vol.113 (5), p.295-302

2004

Volltextzugriff (PDF)

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y 12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet–leukocyte aggregates

Thrombosis research, 2003, Vol.111 (4), p.251-257

2003

Volltextzugriff (PDF)

Thrombolytics : Drug interactions of clinical significance

Drug safety, 2000-11, Vol.23 (5), p.391-399

2000

Volltextzugriff (PDF)

Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans

British journal of clinical pharmacology, 2003-09, Vol.56 (3), p.321-326

2003

Volltextzugriff (PDF)

Dosis-Wirkungs-Beziehung: Relevanz für die ärztliche Praxis

Medizinische Klinik (München. 1983), 1998-12, Vol.93 (12), p.744-749

1998

Volltextzugriff (PDF)

Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects

British journal of clinical pharmacology, 2001-09, Vol.52 (3), p.297-305

2001

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

KollektionThieme Connect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(27)

Sprache

Englisch
(26)
Deutsch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity

Novel Multi-Antigen Orf-Virus-Derived Vaccine Elicits Protective Anti-SARS-CoV-2 Response in Monovalent and Bivalent Formats

Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL Methodology

Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway

Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: Pharmacokinetic and pharmacodynamic considerations

Anticoagulation With Argatroban for Elective Percutaneous Coronary Intervention: Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationship of Coagulation Parameters

A novel μ-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants

408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors

The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow

P3.02c-091 Final Phase Ib Results of RNActive® Cancer Vaccine BI 1361849 and Local Radiation as Maintenance Therapy for Stage IV NSCLC

P3.02c-091 Final Phase Ib Results of RNActive® Cancer Vaccine BI 1361849 and Local Radiation as Maintenance Therapy for Stage IV NSCLC: Topic: IT Clinical

Using ImageJ for the quantitative analysis of flow-based adhesion assays in real-time under physiologic flow conditions

Platelet–leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors

Phenotypic differences of human neutrophils of carriers of the PSGL-1 A and B-allele in binding to immobilised P-selectin under flow conditions

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or anti-platelet therapy: pharmacokinetic and pharmacodynamic considerations

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates

A novel ?-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants

Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y 12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet–leukocyte aggregates

Thrombolytics : Drug interactions of clinical significance

Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans

Dosis-Wirkungs-Beziehung: Relevanz für die ärztliche Praxis

Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects

Aktive Filter

Suchergebnisse filtern